Search Results

Showing results 2141 - 2150 for weill cornell connect patient portal

Single Molecule Imaging Techniques to Aid Crystallization | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/single-molecule-imaging-techniques-aid

Reagents and Methods for Assaying Protein Synthesis and Amino Acid Transport | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/reagents-and-methods-assaying-protein-synthesis-and

ApoM Complex Inhibits Endothelial Cell Injuries | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/apom-complex-inhibits-endothelial-cell-injuries

Past Events | Page 20 | Enterprise Innovation

... Ecosystem menu options BioVenture eLab Center for Technology Licensing at Weill Cornell Medicine Weill...

https://innovation.weill.cornell.edu/news-and-events/past-events?page=19

Novel c-Rel Inhibitors as therapies for Cancer, Inflammatory Disease, Autoimmune Diseases and Transplantation Rejection | Enterprise Innovation

.... Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-c-rel-inhibitors-therapies-cancer

Pan-PPAR Agonists for the Treatment of Tauopathies and Huntington's Disease | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/pan-ppar-agonists-treatment-tauopathies-and

Selective Inhibition of ERK2 for Persistent Inflammatory and Neuropathic Pain | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/selective-inhibition-erk2-persistent-inflammatory

ECG Ordered Contrast Enhanced MRA | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/ecg-ordered-contrast-enhanced-mra

Purine Receptor P2Y Modulators as CNS Therapeutics and In Stem Cell Maintenance and Differentiation | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/purine-receptor-p2y-modulators-cns-therapeutics-and

Telomerase-Immortalized Lines of Human Neural Stem and Progenitor Cells | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/telomerase-immortalized-lines-human-neural-stem-and

Showing results 2141 - 2150 for weill cornell connect patient portal